Understanding Life Expectancy of Cervical Cancer: Factors, Statistics, and Prognosis
Understanding Life Expectancy of Cervical Cancer: Factors, Statistics, and Prognosis" is an informative and comprehensive guide that aims to educate readers on the crucial aspects of cervical cancer life expectancy. This article will help you understand the factors that influence life expectancy, the latest statistics on survival rates, and the prognosis for cervical cancer patients. By raising awareness and emphasizing the importance of early detection, prevention, and appropriate treatment, we hope to contribute to improving life expectancy and overall quality of life for those affected by this disease.
In this guide, we will discuss the different factors that impact cervical cancer life expectancy, including the stage at diagnosis, age, overall health, histological subtypes, and access to healthcare. We will then delve into the most recent statistics on life expectancy of cervical cancer, exploring global and regional variations, survival rates by stage, and trends over time. Additionally, we will examine the prognosis and quality of life for cervical cancer patients, highlighting factors affecting prognosis and strategies to improve the overall well-being of those living with the disease.
Lastly, we will emphasize the importance of prevention and early detection in enhancing life expectancy. This section will cover the significance of HPV vaccination, the benefits of routine screening and Pap smears, and the role of lifestyle choices in risk reduction. We will also touch upon the role of advances in research, treatment, and technology in improving the outlook for cervical cancer patients.
Table of Contents
Understanding Life Expectancy of Cervical Cancer: Factors, Statistics, and Prognosis
1. Introduction
Cervical cancer is a type of malignancy that develops in the cervix, the lower part of the uterus that connects to the vagina. It is one of the most common cancers affecting women worldwide, making it crucial to understand its life expectancy, factors, statistics, and prognosis. This comprehensive guide aims to provide essential information on cervical cancer life expectancy and its influencing factors. We will also delve into the importance of early detection, treatment options, and the role of prevention in improving the overall prognosis of cervical cancer patients.
1.1. Defining Cervical Cancer
Cervical cancer typically originates in the cells lining the cervix. Most cases of cervical cancer are caused by the human papillomavirus (HPV), a sexually transmitted infection. There are various types of HPV, but only a few high-risk strains are responsible for cervical cancer. The two primary histological subtypes of cervical cancer are squamous cell carcinoma, accounting for about 90% of cases, and adenocarcinoma, which represents approximately 10% of cases. These subtypes may have different prognoses and treatment responses.
Early-stage cervical cancer often presents no symptoms, making routine screenings like Pap smears and HPV tests critical for early detection. When symptoms do occur, they may include abnormal vaginal bleeding, pain during intercourse, or pelvic pain. Early diagnosis and treatment significantly improve the chances of a favorable prognosis and life expectancy.
1.2. Importance of Understanding Life Expectancy
Understanding life expectancy for cervical cancer patients is vital for several reasons:
- Awareness: Increased knowledge about cervical cancer life expectancy can help raise public awareness about the disease, encouraging more women to undergo regular screenings and seek appropriate healthcare.
- Support and guidance: Accurate information on life expectancy aids healthcare professionals in providing guidance and support to patients and their families. It can help patients make informed decisions about their treatment options and prepare for the future.
- Research and resource allocation: Life expectancy data is essential for healthcare organizations, policymakers, and researchers in identifying trends, developing effective prevention and treatment strategies, and allocating resources effectively.
- Personalized care: Understanding the factors that affect life expectancy allows healthcare providers to develop personalized care plans for each patient, taking into account their unique circumstances and needs.
In the following sections, we will explore the various factors influencing cervical cancer life expectancy, delve into the latest statistics on survival rates, and discuss the prognosis and quality of life for patients. We will also highlight the importance of prevention and early detection in improving life expectancy and share insights on the role of advances in research, treatment, and technology.
To summarize, understanding life expectancy in cervical cancer is crucial for patients, healthcare providers, and researchers alike. This comprehensive guide serves as an essential resource for those seeking information on the factors, statistics, and prognosis of cervical cancer. By increasing awareness and promoting prevention, we can work together to improve the overall life expectancy and quality of life for cervical cancer patients worldwide.
2. Factors Influencing Life Expectancy in Cervical Cancer
Cervical cancer is a complex disease, and life expectancy can be influenced by several factors, including the stage at diagnosis, age and overall health of the patient, histological subtypes, treatment options and response, and access to healthcare. In this section, we will explore these factors in detail and discuss their impact on life expectancy for cervical cancer patients.
2.1. Stage at Diagnosis
One of the most crucial factors affecting cervical cancer life expectancy is the stage at which the cancer is diagnosed. Early detection significantly improves the chances of successful treatment and long-term survival.
- Stage 0 (Carcinoma in situ): In this stage, abnormal cells are confined to the surface of the cervix and have not invaded deeper tissues. The 5-year survival rate for this stage is close to 100%.
- Stage I: Cancer has not spread beyond the cervix. Depending on the size and invasiveness of the tumor, Stage I is further divided into Stage IA and IB. The 5-year survival rate for Stage I is around 80-95%.
- Stage II: Cancer has spread beyond the cervix but has not reached the pelvic wall or the lower third of the vagina. This stage is further divided into Stage IIA and IIB. The 5-year survival rate for Stage II ranges from 60-75%.
- Stage III: Cancer has reached the pelvic wall or the lower third of the vagina but has not spread to the lymph nodes or distant sites. This stage is further divided into Stage IIIA and IIIB. The 5-year survival rate for Stage III is about 40-55%.
- Stage IV: Cancer has spread to nearby organs or distant sites. This stage is further divided into Stage IVA and IVB. The 5-year survival rate for Stage IV is between 15-30%.
It is important to note that these survival rates are based on historical data and may not fully reflect the outcomes of current treatments and medical advancements.
2.2. Age and Overall Health
Age and overall health can also play a significant role in life expectancy for cervical cancer patients. Younger patients generally have a better prognosis, as they are more likely to withstand aggressive treatments and recover more quickly. Additionally, patients in good overall health may respond more favorably to treatments and have a better chance of survival.
Comorbidities, such as diabetes, cardiovascular diseases, and obesity, can negatively impact the patient's ability to tolerate and respond to treatments. A weakened immune system, due to conditions like HIV/AIDS, can also affect life expectancy, as it makes it harder for the body to fight off cancer and increases the risk of complications during treatment.
2.3. Histological Subtypes
Cervical cancer can be classified into different histological subtypes, primarily squamous cell carcinoma, and adenocarcinoma. Squamous cell carcinoma accounts for about 90% of cervical cancer cases, while adenocarcinoma represents approximately 10% of cases.
Squamous cell carcinoma tends to have a slightly better prognosis compared to adenocarcinoma, as it often responds well to treatment, especially in the early stages. However, the prognosis can vary depending on the specific subtype and stage of the cancer, as well as the patient's individual characteristics.
2.4. Treatment Options and Response
The choice of treatment and the patient's response to it can significantly impact life expectancy. Treatment options for cervical cancer include surgery, radiation therapy, chemotherapy, targeted therapy, and immunotherapy. The optimal treatment plan depends on factors such as the stage of cancer, the patient's overall health, and the potential side effects of each treatment.
Early-stage cervical cancer is often treated with surgery, such as a hysterectomy or a trachelectomy, which can be curative if the cancer has not spread beyond the cervix. In some cases, radiation therapy or chemotherapy may be used in combination with surgery to improve the chances of success.
For locally advanced cervical cancer, concurrent chemoradiation therapy (CRT) – a combination of chemotherapy and radiation therapy – is the standard treatment. The response to CRT can significantly influence life expectancy, as a good response is associated with a higher likelihood of long-term survival.
In cases of metastatic or recurrent cervical cancer, treatment options may be more limited, and the focus may shift to managing symptoms and improving the quality of life. In these situations, chemotherapy, targeted therapy, or immunotherapy may be used to slow cancer progression and alleviate symptoms. The effectiveness of these treatments can vary from patient to patient, affecting life expectancy accordingly.
2.5. Access to Healthcare
Access to healthcare is another crucial factor that can influence life expectancy for cervical cancer. Inadequate access to healthcare can result in delayed diagnosis, limited treatment options, and poorer outcomes. Factors that may affect access to healthcare include:
- Socioeconomic status: Lower-income individuals may face barriers to accessing healthcare, including lack of insurance coverage, inability to afford out-of-pocket expenses, and limited availability of healthcare providers in their area.
- Education and awareness: Insufficient knowledge about cervical cancer, its risk factors, and the importance of routine screenings can lead to delayed diagnosis and reduced life expectancy.
- Geographic location: Patients living in rural or remote areas may have limited access to specialized cancer treatment centers, resulting in suboptimal care and outcomes.
- Cultural and language barriers: Cultural beliefs and language barriers can hinder patient-provider communication, leading to reduced understanding of the disease and limited access to appropriate care.
Efforts to improve access to healthcare, such as expanding insurance coverage, increasing awareness about cervical cancer, and implementing telemedicine services, can help address these disparities and improve life expectancy for cervical cancer patients.
3. Statistics on Life Expectancy of Cervical Cancer
Cervical cancer life expectancy statistics provide valuable insights into the disease's prevalence, survival rates, and overall prognosis. In this section, we will explore global and regional variations in life expectancy, survival rates by stage, and trends over time, providing a comprehensive understanding of the current state of cervical cancer survival and its implications for patients and healthcare providers.
3.1. Global and Regional Variations
Cervical cancer is the fourth most common cancer affecting women worldwide, with an estimated 604,000 new cases and 342,000 deaths in 2020 alone. Life expectancy and survival rates for cervical cancer vary significantly by region, influenced by factors such as access to healthcare, availability of screening and vaccination programs, and socioeconomic conditions.
- High-income countries: In high-income countries, cervical cancer life expectancy and survival rates are generally higher due to widespread access to healthcare, comprehensive screening programs, and HPV vaccination campaigns. For example, in the United States, the 5-year survival rate for cervical cancer is around 66%, while in the United Kingdom, it is about 63%.
- Low- and middle-income countries: In low- and middle-income countries, cervical cancer life expectancy and survival rates tend to be lower. Limited access to healthcare, lack of awareness, and insufficient screening and vaccination programs contribute to a higher prevalence of the disease and poorer outcomes. For instance, the 5-year survival rate for cervical cancer in India is estimated to be around 50%, while in sub-Saharan Africa, it is only 21%.
These disparities highlight the urgent need for improved access to healthcare increased awareness, and expanded screening and vaccination programs in low- and middle-income countries to reduce cervical cancer incidence and improve life expectancy.
3.2. Survival Rates by Stage
Survival rates for cervical cancer are closely linked to the stage at which the disease is diagnosed. As mentioned earlier, early detection significantly improves the chances of successful treatment and long-term survival. The following are the approximate 5-year survival rates for cervical cancer by stage:
- Stage 0 (Carcinoma in situ): Nearly 100%
- Stage I: 80-95%
- Stage II: 60-75%
- Stage III: 40-55%
- Stage IV: 15-30%
Please note that these survival rates are based on historical data and may not fully reflect the outcomes of current treatments and medical advancements. Additionally, individual patient outcomes can vary depending on factors such as age, overall health, histological subtypes, and treatment response.
3.3. Trends Over Time
Over the past few decades, significant progress has been made in improving life expectancy of cervical cancer and survival rates, driven by advancements in screening, prevention, and treatment.
- Screening: The widespread adoption of Pap smear tests and HPV tests has led to earlier detection of cervical cancer and its precursors, resulting in a decline in cervical cancer incidence and mortality rates in many high-income countries. For example, in the United States, cervical cancer incidence rates have decreased by about 1% per year from 2003 to 2017, while mortality rates have declined by about 1.2% per year from 2002 to 2016.
- Prevention: The introduction of HPV vaccines has been a game-changer in cervical cancer prevention. Since their introduction in the mid-2000s, HPV vaccination programs have led to significant reductions in HPV infections, genital warts, and cervical precancers among vaccinated populations. As vaccination coverage continues to expand, it is expected to have a substantial impact on reducing cervical cancer incidence and improving life expectancy in the coming years.
- Treatment: Advances in treatment options, including surgery, radiation therapy, chemotherapy, targeted therapy, and immunotherapy, have contributed to improved survival rates and better quality of life for cervical cancer patients. Innovations in medical technology, such as minimally invasive surgery and advanced radiation therapy techniques, have also enhanced treatment outcomes and reduced complications.
Despite these advancements, significant disparities in cervical cancer life expectancy and survival rates persist, both between and within countries. In many low- and middle-income countries, cervical cancer incidence and mortality rates remain high due to inadequate access to healthcare, insufficient screening and vaccination programs, and limited awareness of the disease.
Efforts to address these disparities and improve cervical cancer life expectancy must focus on:
- Expanding access to healthcare, particularly in low-resource settings, to ensure that all women have access to cervical cancer screening, prevention, and treatment services.
- Increasing awareness of cervical cancer, its risk factors, and the importance of routine screenings and HPV vaccination, through public health campaigns and educational initiatives.
- Strengthening healthcare infrastructure and workforce capacity, to ensure that healthcare providers have the necessary resources and training to effectively diagnose and treat cervical cancer.
- Promoting research and innovation in cervical cancer prevention, early detection, and treatment, to develop new strategies and technologies that can further improve life expectancy and quality of life for cervical cancer patients.
4. Prognosis and Quality of Life
Cervical cancer can have a significant impact on a patient's prognosis and quality of life. In this section, we will discuss factors affecting prognosis, the impacts of cervical cancer on physical and emotional well-being, and strategies to improve the quality of life for those affected by this disease.
4.1. Factors Affecting Prognosis
Prognosis refers to the likely outcome or course of a disease and is influenced by several factors in cervical cancer patients. Some key factors that can affect prognosis include:
- Stage at diagnosis: As discussed earlier, early detection and diagnosis of cervical cancer greatly improve the chances of successful treatment and long-term survival. Patients diagnosed at an early stage generally have a better prognosis than those diagnosed at later stages.
- Age and overall health: Younger patients and those in good overall health tend to have a better prognosis, as they are more likely to withstand aggressive treatments and recover more quickly.
- Histological subtypes: Different histological subtypes of cervical cancer can affect prognosis. Squamous cell carcinoma, which accounts for the majority of cases, typically has a slightly better prognosis compared to adenocarcinoma.
- Treatment options and response: The choice of treatment and the patient's response to it can significantly impact prognosis. Patients who respond well to treatments such as surgery, radiation therapy, chemotherapy, targeted therapy, or immunotherapy are likely to have a better prognosis than those who do not respond as favorably.
- Access to healthcare: Patients who have access to high-quality healthcare, including appropriate diagnostic and treatment services, tend to have better outcomes and prognosis.
4.2. Impact on Physical and Emotional Well-being
Cervical cancer can have far-reaching effects on a patient's physical and emotional well-being. Some common impacts include:
- Physical side effects: Treatments for cervical cancer, such as surgery, radiation therapy, and chemotherapy, can cause a range of physical side effects, including pain, fatigue, sexual dysfunction, fertility issues, and complications related to bladder or bowel function. These side effects can significantly impact a patient's daily life and overall well-being.
- Emotional and psychological distress: A cancer diagnosis can be emotionally overwhelming, leading to feelings of fear, anxiety, depression, and isolation. The uncertainty surrounding prognosis, the impact of treatments on the body, and concerns about the future can contribute to emotional distress and impact the overall quality of life.
- Financial strain: The cost of cancer treatments, loss of income due to inability to work, and out-of-pocket expenses can result in significant financial stress, which can further exacerbate emotional distress and impact quality of life.
- Social and relationship challenges: Cervical cancer can strain personal relationships, as patients and their loved ones may struggle to cope with the emotional and practical demands of the disease. This can result in feelings of loneliness, isolation, and difficulty maintaining social connections.
4.3. Strategies to Improve Quality of Life
Improving the quality of life for cervical cancer patients involves addressing the physical, emotional, and practical challenges that accompany the disease. Some strategies to help patients and their loved ones cope with these challenges include:
- Comprehensive care: Ensuring that cervical cancer patients receive comprehensive, patient-centered care that addresses their physical, emotional, and practical needs is critical. This includes providing access to appropriate diagnostic and treatment services, as well as supportive care, such as pain management, rehabilitation, and mental health services.
- Emotional support: Providing emotional support and resources to help patients cope with the psychological impacts of cervical cancer is essential. This may include access to counseling or therapy, support groups, and educational resources to help patients and their loved ones navigate the emotional challenges of the disease.
- Financial assistance: Addressing the financial strain associated with cervical cancer can help improve the overall quality of life for patients and their families. This may involve connecting patients with financial assistance programs, exploring alternative payment options, and providing resources to help patients manage their financial challenges.
- Education and communication: Educating patients and their loved ones about cervical cancer, its treatments, and potential side effects can help empower them to make informed decisions about their care. Open and honest communication between patients and healthcare providers is also essential for building trust and addressing concerns related to prognosis and quality of life.
- Lifestyle adjustments: Encouraging patients to make healthy lifestyle choices, such as eating a balanced diet, engaging in regular physical activity, and getting enough sleep, can help improve their overall well-being and quality of life during and after treatment.
- Support networks: Connecting patients with support networks, including friends, family, and fellow cancer survivors, can help alleviate feelings of isolation and provide a source of emotional and practical support.
- Addressing sexual health and fertility concerns: Providing resources and support to help patients navigate issues related to sexual health and fertility can improve quality of life and help patients regain a sense of normalcy after treatment. This may include connecting patients with specialized healthcare providers, such as sexual health therapists or fertility specialists, and providing education on available options for preserving fertility or managing sexual dysfunction.
- Palliative and end-of-life care: For patients with advanced or recurrent cervical cancer, palliative care can help improve quality of life by addressing symptoms, managing pain, and providing emotional and spiritual support. It is essential to ensure that patients have access to appropriate palliative care services and that discussions about end-of-life care and preferences are initiated early in the disease trajectory.
5. Prevention and Early Detection
Prevention and early detection play a crucial role in reducing cervical cancer incidence and improving life expectancy. By focusing on HPV vaccination, routine screening, and promoting healthy lifestyle choices, we can make significant strides in the fight against this disease. In this section, we will explore the importance of these strategies and their impact on cervical cancer prevention and early detection.
5.1. Importance of HPV Vaccination
Human papillomavirus (HPV) is a group of viruses known to cause cervical cancer, as well as other cancers and genital warts. Persistent infection with high-risk HPV types, particularly HPV 16 and 18, is responsible for approximately 70% of cervical cancer cases worldwide.
HPV vaccination is a powerful tool in the prevention of cervical cancer. The vaccines currently available protect against the most common high-risk HPV types, significantly reducing the risk of developing cervical cancer and precancerous lesions. The main HPV vaccines available include:
- Gardasil 9: Protects against HPV types 6, 11, 16, 18, 31, 33, 45, 52, and 58.
- Cervarix: Protects against HPV types 16 and 18.
HPV vaccines are most effective when administered before an individual becomes sexually active and exposed to the virus. As such, the World Health Organization (WHO) recommends vaccinating girls aged 9-14 years, with a two-dose schedule. In some countries, HPV vaccination is also recommended for boys, as it can protect against other HPV-related cancers and diseases. Catch-up vaccination is also available for individuals who did not receive the vaccine during the recommended age range.
Since the introduction of HPV vaccines in the mid-2000s, numerous studies have shown a significant decline in HPV infections, genital warts, and cervical precancers among vaccinated populations. As vaccination coverage continues to expand, it is expected to have a substantial impact on reducing cervical cancer incidence and improving life expectancy in the coming years.
5.2. Routine Screening and Pap Smears
Regular cervical cancer screening is essential for the early detection and prevention of the disease. Screening tests, such as Pap smears and HPV tests, can detect cervical cell abnormalities and HPV infections before they progress to cancer. This allows for early intervention and treatment, reducing the risk of developing invasive cervical cancer.
Pap smears, also known as cervical cytology tests, involve the collection of cells from the cervix to check for any abnormalities that may indicate precancerous or cancerous changes. If abnormal cells are detected, further testing and treatment may be necessary to prevent the progression to cervical cancer.
HPV tests detect the presence of high-risk HPV types in cervical cells. A positive HPV test may indicate an increased risk of developing cervical cancer and require additional monitoring and testing.
Cervical cancer screening guidelines vary by country, but generally, it is recommended that women begin screening at age 21 or within a few years of becoming sexually active, whichever comes first. Screening should continue at regular intervals, typically every three to five years, depending on the specific guidelines and the type of test used. Women with certain risk factors, such as a weakened immune system or a history of cervical cancer or precancer, may need more frequent screening.
5.3. Lifestyle Choices and Risk Reduction
In addition to HPV vaccination and regular screening, making healthy lifestyle choices can help reduce the risk of developing cervical cancer. Some key lifestyle choices and risk-reduction strategies include:
- Safe sex practices: Since HPV is primarily transmitted through sexual contact, practicing safe sex is essential for reducing the risk of infection. Using condoms consistently and correctly, limiting the number of sexual partners, and being in a mutually monogamous relationship can help lower the risk of HPV exposure.
- Smoking cessation: Smoking has been linked to an increased risk of cervical cancer, as harmful chemicals in tobacco can damage cervical cells and facilitate the progression of HPV infections to cancer. Quitting smoking or avoiding it altogether can significantly reduce the risk of developing cervical cancer.
- Maintaining a healthy diet: A balanced diet rich in fruits, vegetables, and whole grains provides essential nutrients that support a healthy immune system. A strong immune system is better equipped to fight off HPV infections and prevent the development of cancer.
- Regular physical activity: Engaging in regular physical activity can help maintain a healthy body weight and support overall health, including the immune system. This may help reduce the risk of developing cervical cancer.
- Limiting alcohol consumption: Excessive alcohol consumption has been associated with an increased risk of several types of cancer, including cervical cancer. Limiting alcohol intake or avoiding it altogether can help reduce the risk of developing cervical cancer.
- Addressing other risk factors: Some other risk factors for cervical cancer include long-term use of oral contraceptives, having a weakened immune system, or exposure to diethylstilbestrol (DES) in utero. Discussing these risk factors with a healthcare provider and taking appropriate steps to mitigate them can help reduce the risk of developing cervical cancer.
6. Conclusion and Future Directions
Cervical cancer remains a significant global health concern, but recent advances in research, treatment, awareness, and technology offer hope for improved life expectancy and quality of life for those affected by the disease. In this conclusion, we will discuss the importance of continued progress in these areas and the potential for future developments to revolutionize cervical cancer prevention, detection, and management.
6.1. Advances in Research and Treatment
Continued investment in research is essential for discovering new and more effective methods for preventing, detecting, and treating cervical cancer. Recent advances in targeted therapies and immunotherapies have shown promise in improving treatment outcomes and reducing side effects. Additionally, research into novel biomarkers and personalized medicine approaches may further refine our understanding of cervical cancer risk and enable tailored prevention and treatment strategies.
6.2. Promoting Awareness and Advocacy
Raising awareness about cervical cancer, its risk factors, and the importance of prevention and early detection is crucial for reducing its incidence and improving outcomes. Public health campaigns, educational initiatives, and advocacy efforts must focus on promoting HPV vaccination, routine screening, and healthy lifestyle choices, particularly in underserved populations and regions with high cervical cancer incidence.
Efforts to raise awareness should also aim to reduce stigma and misconceptions surrounding cervical cancer, HPV, and sexual health, empowering individuals to make informed decisions about their health and fostering a supportive environment for those affected by the disease.
6.3. The Role of Technology in Early Detection and Management
Technology has the potential to revolutionize cervical cancer detection and management, making it more accessible, efficient, and accurate. Some key areas where the technology may play a crucial role include:
Remote screening and diagnostics: Telemedicine and digital health platforms can enable remote cervical cancer screening and follow-up consultations, particularly for individuals with limited access to healthcare facilities. Mobile applications and devices that facilitate self-sampling for HPV testing may also improve screening coverage and convenience.
Artificial intelligence (AI) and machine learning: AI algorithms and machine learning tools can be utilized to analyze medical images, such as Pap smear slides or colposcopy images, potentially improving the accuracy and efficiency of cervical cancer screening. AI-based models can also help identify high-risk individuals or predict treatment responses, enabling personalized prevention and management strategies.
Electronic health records (EHRs) and data-driven insights: The integration of EHRs, screening registries, and population health data can help identify gaps in cervical cancer care and inform targeted interventions. Data-driven insights can also guide the development of more effective public health policies and resource allocation.
Patient support and education: Digital platforms and mobile applications can provide cervical cancer patients and their loved ones with access to educational resources, support networks, and tools for managing their health, helping to improve their overall well-being and quality of life.
In conclusion, the future of cervical cancer prevention, detection, and management lies in embracing advances in research, treatment, awareness, and technology to improve the life expectancy of cervical cancer patients. By investing in these areas and fostering collaboration between healthcare providers, researchers, policymakers, and patient advocates, we can continue to make progress in the fight against cervical cancer and improve life expectancy and outcomes for those affected by the disease.
Post a Comment for "Understanding Life Expectancy of Cervical Cancer: Factors, Statistics, and Prognosis"